BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women
In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review
Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion
NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG
Three New RFAs Announced In Cancer Control
Trending Stories
- Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Kevan Shokat made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Iowa’s “cancer crisis” emerges as a top issue on the campaign trail
- California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









